Directory
>
Frank Stegmeier
Frank Stegmeier
Board Member | Curie.Bio
Acton, Massachusetts, United States
Frank Stegmeier
Summary
Frank Stegmeier is a seasoned professional in the life sciences sector with a strong background in oncology and drug discovery. He currently serves as a CSO Partner at Curie.Bio, where he leverages his extensive expertise in biochemistry, bioinformatics, and functional genomics. With a Ph.D. from MIT and a postdoctoral fellowship at Harvard Medical School, Frank has cultivated a deep understanding of cancer biology and biomarker discovery. His leadership roles at Ksq Therapeutics and Addgene demonstrate his commitment to advancing pharmaceutical research. Frank's innovative approach to drug development is underscored by his work on high-complexity barcoding techniques for cancer therapy. He is passionate about harnessing technology to improve patient outcomes and is actively involved in strategic collaborations within the industry. His journey reflects a blend of scientific rigor and entrepreneurial spirit, positioning him as a thought leader in biotechnology.
Frank Stegmeier
Work Experience
Board Member at
KSQ Therapeutics, Inc.
November 2022 - Present
CSO Partner at
Curie.Bio
November 2022 - Present
Board Member at
Addgene
March 2020 - Present
Chief Scientific Officer at
KSQ Therapeutics, Inc.
December 2015 - November 2022
Head of Oncology Target Discovery at
Novartis
June 2010 - November 2015
Director, Head of Cambridge Target Validation, Oncology at
Novartis
April 2013 - November 2013
Research Investigator, Oncology at
Novartis
April 2007 - August 2010
Postdoctoral Fellow at
Harvard University
January 2004 - January 2007
Frank Stegmeier
Education
Harvard University, Postdoc
January 2004 - January 2007
Massachusetts Institute of Technology, Ph.D.
January 1999 - January 2004
University of Tübingen, B.S.
January 1996 - January 1999
Frequently Asked Questions about Frank Stegmeier
What is Frank Stegmeier email address?
Frank Stegmeier's primary email address is **********@ksqtx.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Frank Stegmeier work for?
Frank Stegmeier is a Board Member at Curie.Bio.
Where Frank Stegmeier graduated from?
Frank Stegmeier holds a degree in Genetics / Biology from Harvard University.
How can I directly contact Frank Stegmeier?
To contact Frank Stegmeier directly, you can use the email address **********@ksqtx.com. Complete contact information is available upon registration with Muraena.
Who is Frank Stegmeier?
Frank Stegmeier is a seasoned professional in the life sciences sector with a strong background in oncology and drug discovery. He currently serves as a CSO Partner at Curie.Bio, where he leverages his extensive expertise in biochemistry, bioinformatics, and functional genomics. With a Ph.D. from MIT and a postdoctoral fellowship at Harvard Medical School, Frank has cultivated a deep understanding of cancer biology and biomarker discovery. His leadership roles at Ksq Therapeutics and Addgene demonstrate his commitment to advancing pharmaceutical research. Frank's innovative approach to drug development is underscored by his work on high-complexity barcoding techniques for cancer therapy. He is passionate about harnessing technology to improve patient outcomes and is actively involved in strategic collaborations within the industry. His journey reflects a blend of scientific rigor and entrepreneurial spirit, positioning him as a thought leader in biotechnology.
Frank`s contact details
**********@ksqtx.com
*****@curie.bio
Colleagues
Investor